EpiVax's Grant

EpiVax raised a round of funding on June 15, 1998. Investors include Slater Center for Biomedical Technology.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant: